CAS 284661-68-3

N-(aminoacetyl)-N~2~-[(1S)-3-{[(3-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-benzyl-2-hydroxypropyl]-N~2~-(3-fluorobenzyl)-3-methyl-D-valinamide

Description:

N-(aminoacetyl)-N~2~-[(1S)-3-{[(3-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-benzyl-2-hydroxypropyl]-N~2~-(3-fluorobenzyl)-3-methyl-D-valinamide, identified by CAS number 284661-68-3, is a complex organic compound characterized by its multi-functional structure. It features an aminoacetyl group, which contributes to its potential biological activity, particularly in medicinal chemistry. The presence of a sulfonamide moiety indicates possible interactions with biological targets, such as enzymes or receptors, making it of interest in drug design. The compound also contains multiple chiral centers, suggesting that it may exhibit stereospecific properties, which can influence its pharmacokinetics and pharmacodynamics. Additionally, the incorporation of a fluorobenzyl group may enhance lipophilicity and metabolic stability. Overall, this compound's intricate structure suggests potential applications in therapeutic areas, particularly in the development of novel pharmaceuticals targeting specific biological pathways. However, detailed studies would be necessary to fully elucidate its properties and potential uses.

Formula: C₃₅H₄₈FN₅O₅S

InChI: InChI=1/C35H48FN5O5S/c1-24(2)21-40(47(45,46)29-16-10-15-28(38)19-29)23-31(42)30(18-25-11-7-6-8-12-25)41(22-26-13-9-14-27(36)17-26)33(35(3,4)5)34(44)39-32(43)20-37/h6-17,19,24,30-31,33,42H,18,20-23,37-38H2,1-5H3,(H,39,43,44)/t30-,31?,33-/m0/s1

SMILES: CC(C)CN(CC([C@H](Cc1ccccc1)N(Cc1cccc(c1)F)[C@@H](C(=O)N=C(CN)O)C(C)(C)C)O)S(=O)(=O)c1cccc(c1)N

DPC-681

CAS: 284661-68-3

DPC-681 is a molecule that has been shown to have inhibitory properties against viruses and cancer cells. The compound is chemically diverse, containing both nucleoside and non-nucleoside components. DPC-681 has been shown to be effective in the treatment of inflammatory bowel disease (IBD) and ischemia reperfusion injury in animal models. It also has anticancer activity, inhibiting the proliferation of colon cancer cells. DPC-681 also has an active role in HIV infection; it inhibits viral replication by blocking the chemokine CXCL4/MIP1β pathway. This drug may be useful for patients with active antiretroviral therapy (ART).

Formula: C₃₅H₄₈FN₅O₅S

Purity: Min. 95%

Molecular weight: 669.85 g/mol

Ref: 3D-JLA66168

DPC-681

CAS: 284661-68-3

DPC-681 is a potent and selective HIV protease inhibitor (IC90s: 4 to 40 nM for wild-type HIV-1).

Formula: C₃₅H₄₈FN₅O₅S

Color and Shape: Solid

Molecular weight: 669.85

Ref: TM-T15163